iXensor Receives Strategic Investment from Rohto Pharmaceutical with A Separate Technology Licensing Agreement | Business
April 27th, 2022 | 🕒
TTS TAIPEI, Taiwan & OSAKA, Japan--(BUSINESS WIRE)--Apr 27, 2022-- iXensor Co., Ltd. (6734. TWO) This press release features multimedia. View
Gloss